Leuphasyl vs Acetyl Hexapeptide-3 (Argireline) — Peptide Comparison

At a Glance

Quickcomparison

Dose Range

Leuphasyl

As prescribed–As prescribed mg

Acetyl Hexapeptide-3 (Argireline)

5%–10% %

Frequency

Once daily

Administration

Topical application (serums, creams, ampoules)

Topical

Cycle Length

Ongoing/indefinite

Onset Speed

Slow (5+ weeks)

Moderate (1-2 weeks)

Evidence Level

Moderate human trials (Phase 1-2)

Limited human trials

Efficacy

Benefitratings

Wrinkle Reduction

Skin Smoothing

Anti-Aging Prevention

Expression Wrinkle Reduction

Non-Invasive Treatment

Safety Profile

Technical Data

Compoundspecifications

Molecular Formula

C29H39N5O7

Molecular Weight

569.65 g/mol

Half-Life

Topical application (local activity, systemic half-life not applicable)

Bioavailability

Limited (topical peptide; skin penetration challenged by hydrophilic nature and molecular size)

CAS Number

64963-01-5

C35H62N14O11S

887.0 Da

Topical stability dependent on formulation; methionine residue susceptible to oxidation; stable at pH 5.5-7.7

Limited skin penetration (0.22-0.54%); primarily acts at stratum corneum and superficial epidermis; O/W emulsions enhance delivery

616204-22-9

Protocols

Dosingtiers

starting

2% Leuphasyl in formulation

Once or twice daily

4-8 weeks

Lowest concentration shown to give significant wrinkle reduction in cosmetic testing; 2% was the threshold at which measurable improvement appeared over ~2 months of daily use [6].

standard

5% Leuphasyl in formulation

At least 4 weeks

Manufacturer in-vivo concentration; 5% Leuphasyl reduced wrinkles ~11% after 28 days, and ~25% (up to 47%) when paired with 5% Argireline [6].

5-10% concentration (cream or serum)

Twice daily (morning and evening)

Minimum 28-30 days; ongoing use to maintain effect

Used as a leave-on skin cream or serum. In studies, a 10% formula applied twice a day around the eyes reduced wrinkle depth by about 17% after 15 days and up to 27-30% after 30 days. It works on the skin surface only and is not injected. [1][2]

Applications

Bestsuited for

Expression line reduction

Leuphasyl is particularly well-suited for individuals focused on expression line reduction. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

Fine line prevention

Leuphasyl is particularly well-suited for individuals focused on fine line prevention. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

Age management

Leuphasyl is particularly well-suited for individuals focused on age management. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

Non-invasive wrinkle reduction

Leuphasyl is particularly well-suited for individuals focused on non-invasive wrinkle reduction. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

Individuals seeking non-invasive reduction of expression lines and dynamic wrinkles

Acetyl Hexapeptide-3 (Argireline) is particularly well-suited for individuals focused on individuals seeking non-invasive reduction of expression lines and dynamic wrinkles. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

Those with needle phobia who want botulinum toxin-like effects without injections

Acetyl Hexapeptide-3 (Argireline) is particularly well-suited for individuals focused on those with needle phobia who want botulinum toxin-like effects without injections. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

People targeting crow's feet, forehead lines, and glabellar creases

Acetyl Hexapeptide-3 (Argireline) is particularly well-suited for individuals focused on people targeting crow's feet, forehead lines, and glabellar creases. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

Individuals looking for preventive anti-wrinkle treatment to slow expression line formation

Acetyl Hexapeptide-3 (Argireline) is particularly well-suited for individuals focused on individuals looking for preventive anti-wrinkle treatment to slow expression line formation. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

Sideeffects

Common

Mild discomfort at treatment site

Mild skin tingling

Mild redness at application site

Uncommon

Temporary skin dryness

Serious

Severe allergic reaction

Mild Skin Irritation

Transient Redness

Slight Dryness

Stinging on Compromised Skin

Contact Dermatitis

Allergic Contact Dermatitis

Research Status

Safety& evidence

FDA Status

Research compound

Safety Overview

Leuphasyl (Pentapeptide-18) has been studied in cosmetic research for over 15 years. This topical enkephalin-mimetic peptide demonstrates an excellent safety profile in cosmetic formulations, with no reported serious adverse effects in clinical applications. As a topical cosmetic ingredient, it avoids systemic absorption concerns associated with injectable treatments. The peptide is well-tolerated across all skin types including sensitive skin. Individual responses can vary with formulation and concentration, but most effects are manageable with standard cosmetic application protocols.

Contraindications

xKnown hypersensitivity to peptides

xOpen wounds or broken skin at application site

xActive dermatological infections at application site

Acetyl Hexapeptide-3 demonstrates an excellent safety profile for topical cosmetic use with no serious adverse events reported in clinical studies. At the 10% concentrations used in cosmetic formulations, systemic absorption is minimal and no neurotoxicity has been observed despite its mechanism of action on the neuromuscular junction. The peptide shows a safety margin of approximately 100-fold compared to toxic reference compounds. Primary concerns are limited to local skin irritation in sensitive individuals, such as mild erythema, transient stinging, or contact dermatitis in those with peptide hypersensitivity.

xKnown hypersensitivity to acetyl hexapeptide-3 or formulation components

xActive skin infections or open wounds at the application site

xNo known systemic contraindications at cosmetic concentrations

xUse with caution in individuals with neuromuscular disorders (theoretical concern)

Decision Guide

Which isright for you?

Choose Leuphasyl if...

Expression line reduction

Fine line prevention

Age management

Non-invasive wrinkle reduction

Choose Acetyl Hexapeptide-3 (Argireline) if...

Individuals seeking non-invasive reduction of expression lines and dynamic wrinkles

Those with needle phobia who want botulinum toxin-like effects without injections

People targeting crow's feet, forehead lines, and glabellar creases

Individuals looking for preventive anti-wrinkle treatment to slow expression line formation